MAOA, MAOB: Monoamine oxidase
Family in Homo sapiens that 8 drugs act on.
- Drugs that act on it: 8
- Approved: 8
- In phases 1 to 3: 0
- Sponsors: 4
Who is on it, and how far along
Every drug ChEMBL records acting on MAOA, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 8
Approved8
Phase 30
Phase 20
Phase 10
Sponsors
Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.
- Abbott Laboratories113%
- ADVANZ PHARMA113%
- Lifsa Drugs113%
- Pfizer113%
| PhenelzineBoxed warning | Approved | Pfizer | Small molecule | Inhibitor | 2 |
| TranylcypromineBoxed warning | Approved | ADVANZ PHARMA | Small molecule | Inhibitor | 2 |
| Iproniazid | Approved | — | Small molecule | Inhibitor | 0 |
| IsocarboxazidWithdrawn Boxed warning | Approved | Lifsa Drugs | Small molecule | Inhibitor | 0 |
| MebanazineWithdrawn | Approved | — | Small molecule | Inhibitor | 0 |
| NialamideWithdrawn | Approved | — | Small molecule | Inhibitor | 0 |
| Pargyline | Approved | Abbott Laboratories | Small molecule | Inhibitor | 0 |
| PhenoxypropazineWithdrawn | Approved | — | Small molecule | Inhibitor | 0 |
| Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery | Tranylcypromine | Phase 4 | Recruiting | Patel Hospital, Pakistan | Aug 1, 2025 |
| Precision Care for Major Depressive Disorder | Phenelzine | Phase 4 | Enrolling by invitation | University of California, San Francisco | Aug 30, 2024 |
| Efficacy of Hydroxyzine for Patients With Panic Disorder | Phenelzine, Tranylcypromine | Phase 4 | Not yet recruiting | Sultan Qaboos University | Feb 21, 2023 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2095205, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets